Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create  transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach more than 800 million people globally and we are finding innovative ways to expand access to our latest treatments. About 109,000 people of more than 145 nationalities work at Novartis around the world. Find out more at www.novartis.com.

The California Sickle Cell Data Collection program is grateful to be part of the Educational Summit – Congratulations on another year of this engaging, helpful program.

Vertex, a global biotechnology company, is focused on developing transformative medicines for people with serious diseases by fostering meaningful partnerships and collaborations. Patients are at our core, and Vertex is honored and proud to support the 14^th Annual Sickle Cell Disease Educational Summit and the broader SCD community. Through active engagement and dialogue with the Warrior community, Vertex is committed to supporting and standing with our communities as we investigate potential approaches to treating disease.

GBT is working to discover, develop and deliver life-changing treatments for people living with grievous blood based disorders, starting with sickle cell disease.

Agios is a biopharmaceutical company that is fueled by connections. The Agios team is dedicated to developing therapies for genetically defined diseases, and is researching a potential treatment for sickle cell disease. Agios is proud to partner with Cayenne Wellness to support sickle cell warriors!

Graphite Bio is a clinical-stage, next-generation gene editing company driven to discover and develop cures for serious and life-threatening diseases, starting with sickle cell disease.